Genetech Inc - Pharmatrack

Scope eKnowledge Center Pvt Ltd, August 2004, Pages: 26

PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value added research product.This report profiles Genetech Inc. <BR><BR>Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the company’s business structure and operations, products and services. It extensively discusses the company’s financial performance and strategic imperatives from an investor’s perspective and provides a reliable outlook for the future.<BR><BR>Scope of the Report<BR>- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making<BR>- Analyzes the industry and the segment to which the company belongs in a concise manner.<BR>- Compares the company vis-à-vis its peers in a detailed manner<BR>- Discusses also the current industry status and the significant trends that influence the industry<BR>- Tracks key initiatives of the company in the recent period across strategic areas of focus<BR>- Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)<BR>- Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams<BR>- Scope’s comment on the company’s outlook for the forthcoming period – strategic and financial<BR>- Supplementary information such the key industry players, overall industry financial and market performance, company’s board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods. <BR>

- Company Brief <BR><BR>- Key Highlights <BR>Stock Data – Last 3 years to date <BR>Stock Data – Last 52 weeks <BR><BR>- Industry Overview <BR><BR>- Industry Performance Analysis <BR><BR>- Industry Trends <BR>Mergers and Acquisitions <BR>Strategic Alliances <BR>Biotech Investments by Pharma Majors <BR>Increasing Research and Development Spending <BR>Increasing Number of Biotech IPOs <BR>More Competition from Biogenerics <BR>Personalized Medicine Gains Prominence <BR>Systems Biology and Molecular Diagnostics – Rapid Growth Areas<BR>Increased focus in Emerging Biotechnology Fields <BR>Market Expansions <BR>Facility Expansions Integrated With Outsourcing <BR><BR>- Company Overview <BR>Business Overview <BR><BR>- Management Board <BR><BR>- Shareholding Pattern <BR>Insider Ownership <BR>Institutional Ownership <BR>Public <BR><BR>- Major Operations <BR>Operational and Marketing Base <BR>Strong Product Portfolio <BR>Ongoing Programs <BR><BR>- Key Partnerships <BR>Marketing Alliances <BR>Manufacture and R&D Alliances <BR><BR>- Market Position – Comparison with Industry Peers <BR><BR>- Strategic Overview <BR>SWOT Analysis <BR>Strategic Focus <BR>Strong Product Pipeline <BR>Strengthening Of Manufacturing & Marketing Resources <BR>Strategic Alliances <BR><BR>- Financial Performance <BR>Second Quarter Sales Led By Rituxan, Herceptin & Avastin…<BR>Full –Year Performance <BR><BR>- Risk Factors <BR><BR>- Outlook

Customers who bought this item also bought

• The Future of Personalized Medicine: The Impact of Proteomics on Drug Discovery And Clinical Trial Design
• Pharma/Medical Device/Diagnostics Licensing and Collaborations – Evaluating the Deal Structure
• Eli Lilly and Company - Pharmatrack
• GlaxoSmithKline - Pharmatrack
• Pfizer Inc - Pharmatrack
• Roche Holding - Pharmatrack
• Datascope Corporation - Pharmatrack
• ICON Plc. - PharmaTrack
• Serono SA - Pharmatrack
• Serologicals - Pharmatrack